We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J, Janssen Win Mass. Risperdal Suit On Teen's Weight Gain

Law360 (September 5, 2018, 5:26 PM EDT) -- Johnson & Johnson and its subsidiary Janssen Pharmaceuticals Inc. on Wednesday prevailed over claims in Massachusetts federal court saying their antipsychotic drug Risperdal caused a Bay State man to gain excessive...
To view the full article, register now.




Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only



Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability


Subscribers Only

Date Filed

November 30, 2015

Law Firms


Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.